RAC1 activation mediates Twist1-induced cancer cell migration
- PMID: 22407364
- DOI: 10.1038/ncb2455
RAC1 activation mediates Twist1-induced cancer cell migration
Abstract
Epithelial-mesenchymal transition (EMT), which is characterized by the suppression of the adhesion protein E-cadherin, is a crucial process that promotes metastasis and stem-like properties of cancer cells. However, the dissociation of cellular aggregates is not sufficient to explain why cancer cells move, and the motile nature of cancer cells undergoing EMT remains elusive. Here, we identify a mechanism in which the EMT inducer Twist1 elicits cancer cell movement through activation of RAC1. Twist1 cooperates with BMI1 to suppress let-7i expression, which results in upregulation of NEDD9 and DOCK3, leading to RAC1 activation and enabling mesenchymal-mode movement in three-dimensional environments. Moreover, the suppression of let-7i contributes to Twist1-induced stem-like properties. Clinically, activation of the Twist1-let-7i-NEDD9 axis in head and neck cancer patients correlates with tumour invasiveness and worse outcome. Our results uncover an essential mechanism to explain how Twist1 induces the motile stem-like cancer cell phenotype beyond simply suppressing E-cadherin.
Comment in
-
Twists and turns of invasion.Nat Cell Biol. 2012 Apr 2;14(4):337-9. doi: 10.1038/ncb2477. Nat Cell Biol. 2012. PMID: 22469829
Similar articles
-
Twists and turns of invasion.Nat Cell Biol. 2012 Apr 2;14(4):337-9. doi: 10.1038/ncb2477. Nat Cell Biol. 2012. PMID: 22469829
-
Imipramine blue halts head and neck cancer invasion through promoting F-box and leucine-rich repeat protein 14-mediated Twist1 degradation.Oncogene. 2016 May 5;35(18):2287-98. doi: 10.1038/onc.2015.291. Epub 2015 Aug 10. Oncogene. 2016. PMID: 26257063 Free PMC article.
-
Emodin represses TWIST1-induced epithelial-mesenchymal transitions in head and neck squamous cell carcinoma cells by inhibiting the β-catenin and Akt pathways.Eur J Cancer. 2014 Jan;50(2):366-78. doi: 10.1016/j.ejca.2013.09.025. Epub 2013 Oct 21. Eur J Cancer. 2014. PMID: 24157255
-
Epithelial-mesenchymal transition and cancer stemness: the Twist1-Bmi1 connection.Biosci Rep. 2011 Dec;31(6):449-55. doi: 10.1042/BSR20100114. Biosci Rep. 2011. PMID: 21919891 Review.
-
The interplay between microRNAs and Twist1 transcription factor: a systematic review.Tumour Biol. 2016 Jun;37(6):7007-19. doi: 10.1007/s13277-016-4960-y. Epub 2016 Feb 15. Tumour Biol. 2016. PMID: 26880587 Review.
Cited by
-
The heterochronic microRNA let-7 inhibits cell motility by regulating the genes in the actin cytoskeleton pathway in breast cancer.Mol Cancer Res. 2013 Mar;11(3):240-50. doi: 10.1158/1541-7786.MCR-12-0432. Epub 2013 Jan 21. Mol Cancer Res. 2013. PMID: 23339187 Free PMC article.
-
The Epithelial-Mesenchymal Transcription Factor SNAI1 Represses Transcription of the Tumor Suppressor miRNA let-7 in Cancer.Cancers (Basel). 2021 Mar 23;13(6):1469. doi: 10.3390/cancers13061469. Cancers (Basel). 2021. PMID: 33806868 Free PMC article.
-
Epithelial-mesenchymal transition of ovarian cancer cells is sustained by Rac1 through simultaneous activation of MEK1/2 and Src signaling pathways.Oncogene. 2017 Mar;36(11):1546-1558. doi: 10.1038/onc.2016.323. Epub 2016 Sep 12. Oncogene. 2017. PMID: 27617576 Free PMC article.
-
Role of Akt/Protein Kinase B in Cancer Metastasis.Biomedicines. 2023 Nov 8;11(11):3001. doi: 10.3390/biomedicines11113001. Biomedicines. 2023. PMID: 38002001 Free PMC article. Review.
-
Let-7 as biomarker, prognostic indicator, and therapy for precision medicine in cancer.Clin Transl Med. 2019 Aug 28;8(1):24. doi: 10.1186/s40169-019-0240-y. Clin Transl Med. 2019. PMID: 31468250 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials